Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease

Condition:   Sickle Cell Disease Intervention:   Drug: Alemtuzumab intravenously, low dose total body irradiation, Sirolimus Sponsors:   Allistair Abraham, MD;   Alberta Children's Hospital;   The Hospital for Sick Children Recruiting

Source: ClinicalTrials.gov - July 16, 2018 Category: Research Source Type: clinical trials